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Experimental allergic encephalomyelitis (EAE) is a model for autoimmune dis-
ease mediated by antigen-specific, class II-restricted T cells. The autoantigen in EAE
is myelin basic protein (MBP), a 17-kD multideterminant protein from CNS myelin
(1). As for othermurine T cell-mediated autoimmune diseases, susceptibility to EAR
is associated with allelic I-A class II molecules (1-3). Initial investigations demon-
strated that encephalitogenic determinants were located only within the NH2-ter-
minal 1-37 and COOH-terminal 89-169 MBP fragments (1). Encephalitogenic T
cell epitopes within these two fragments have been identified. T cell recognition of
MBP pl-11 is restricted by I-A° (2), and recognition of MBP p89-101 is restricted
by I-As (3). I-E-restricted antigen-specific T cells that participate in EAE or other
murine autoimmune diseases have not been previously identified.
In this report, we have examined the specificity of a T cell clone that recognizes
intact MBP only in association with hybrid I-E class II molecules. This clone does
not recognize MBP 1-37 or MBP 89-169. Using a recently described method for
predictingT cell epitopes of protein antigens (4), the epitope recognized by this clone
has been identified. This determinant includes MBP residues 35-47 . Reactivity to
this portion of MBP has not been previously reported. When tested in vivo, MBP
p35-47 causes EAR T cell recognition ofp35-47 is restricted by I-E molecules. This
is the firstexample demonstrating that antigen-specific T cells restricted by I-E mol-
ecules participate in autoimmune disease. Furthermore, it is now clear that there
are multiple (at least three) discrete encephalitogenic T cell epitopes within the auto-
antigen MBP, each recognized in association with separate allelic I-A and I-E mole-
cules. These results may be relevant to human autoimmune disease whose suscepti-
bility is associated with more than one allelic HLA-D molecule.
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Materials and Methods
Brief Definitive Report
Mice.
￿
PL/J, SJL/J, and (PL/J x SJL/J)Fi([PLSJ]Fl ) female mice were purchased from
TheJackson Laboratory, Bar Harbor, ME.
Antigens.
￿
MBP peptides were synthesized by solid phase techniques (2) accordingto the
sequences formouse MBP (5). All peptides contained>907o ofthe desired product as deter-
mined by high pressure liquid phase column and amino acid (aa) analysis.
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T Cell Clones.
￿
T cell clone F,-28, isolated from a (PLSJ)FI mouse immunized with in-
tact rat MBP, recognizes MBP in association with hybrid I-E(EQ°Egg) and causes EAE in
the same manner that we have described for other MBP-specific T cell clones (2). Other T
cell clones were isolated from individual PL/J and (PLSJ)F, mice following the protocol de-
scribed (2).
Proliferation Assay.
￿
As described previously (2), 104 T cells were cultured with 5 x 105 7-
irradiated (3,000 rad) PL/J splenic APC and the desired peptide in 0.2 ml culture media
in 96-well flat-bottomed microtiter plates (model 3072; Falcon Labware, Oxnard, CA). At
48 h incubation, each well was pulsed with 1 gCi [3H]thymidine and harvested 16 h later.
Mean cpm thymidine incorporation was calculated for triplicate cultures. SD from replicate
cultures were within 10% mean value.
Induction ofEAE with MBPPeptides.
￿
Each peptide was given as an emulsion containing
CFA and PBS in a 1 :1 mixture with 4 mg/ml H37Ra (Difco Laboratories, Inc., Detroit,
MI). Each mouse was injected with the peptide emulsion at the base of the tail. Heat-killed
pertussis organisms (10'0) (Michigan Dept. of Health, lot 9113) were injected intravenously.
2 d later, a second i.v. injection of pertussis organisms was given.
niAbs.
￿
T cell clones were examined with TCR Vpa-specific mAb by FAGS analysis as de-
scribed previously (6). mAb KJ16 binds a determinant associated with the expression oftwo
members of the Vpa subfamily, Vpa., and Vga.2, and F23 .1 binds a determinant associated
with expression of all three members of the Vpa subfamily (7). Vpa' clones were stained posi-
tive with both antibodies.
Results and Discussion
T cell clone F1-28, isolated from a (PLSJ)F1 mouse immunized with intact rat
MBP, proliferates to intact rat or mouse (self) MBP, and is restricted to hybrid I-
Ea°Eos molecules. F1-28 causes EAE in (PLSJ)Fl mice, as we have described for
other MBP-specific T cell clones (2). However, this clone does not recognize any
ofthe peptic MBPfragments. In a recent study, which examined >50 antigenicpep-
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FIGURE 1.
￿
Specificity ofan encephalitogenic
MBP-specific Tcell clonerestricted by hybrid
I-E (EQ°Epg) class II molecules. (A) Peptides
p30-52, p31-45, and p35-47 were tested for
theirability to stimulate proliferation of T cell
clone FI-28. (B) T cell clone FI-28 prolif-
erates to peptides p35-47, p36-47, p37-47, and
p38-47. Proliferative responses were deter-
minedasdescribedinMaterialsandMethods.ZAMVIL ET AL.
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TABLE I
Induction of EAE with Synthetic MBP Peptides
EAE was induced with MBP peptides as described in Materials and
Methods .
Severity was graded as follows: 0, no sign o£ EAE; 1, decreased tail
tone only; 2, mild paraparesis; 3, moderately severe paraparesis; 4, com-
plete paraplegia; 5, moribund.
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tides recognized by Tcells, asequence pattern common to a majority ofepitopes was
identified (4). This pattern includes acore of four contiguous amino acids, acharged
residue or glycine, followed by two hydrophobic residues, and in the next position,
a charged or polar amino acid (4). With this template, we predicted that F1-28
would recognize peptides including the sequence 36-39 (GILD) or 42-45 (RFFS).
When tested in vitro, MBP peptide p30-52, which encompasses thesetwotetramers,
stimulates proliferation of F1-28 (Fig. 1 A). F1-28 also proliferates to peptides p35-
52 and p35-47, but only weakly to p31-45. Although Fl-28 proliferates to p36-47,
p37-47, and p38-47, progressively higher concentrations of peptide are required (Fig.
1 B). These results indicate that COOH residues 45-47 are necessary to complete
the epitope recognized by this clone.
Peptidep35-47 wastested in vivo forinduction ofEAE. MBP p35-47 is encephalito-
genic in homozygous PL/J (H-2°) and (PLSJ)Fl mice (Table I). Histologic signs
of EAE, including perivascular infiltrates of mononuclear cells within the central
nervous system were observed in PL/J and (PISJ)F1 mice immunized with p35-
47 . However, H-2s strain mice, SJL/J or BIO.S (0/10) immunized with p35-47, did
not develop clinical or histologic signs of EAE (Table I). The overlapping peptide
p31-45, which is weakly stimulatory (Fig. 1 A), did not cause EAE.
Lymphocytes isolated from PL/J and (PLSJ)F1 mice immunized with p35-47
proliferate in vitro when cultured with p35-47 . The proliferative response to MBP
p35-47 is inhibited by mAbs specific forI-E, but not I-A, demonstrating that T cell
recognition ofp35-47 is restricted by I-E molecules. T cell clones specific for p35-47
that were isolated from (PLSJ)Fl mice are restricted by either homozygous I-
E(Ea°Eou) molecules or hybrid I-E(Ea°Ed$) molecules. PL/J MBP p35-47-specific
Tcell clones are restricted by homozygous I-E molecules. Representative clones are
shown in Table II. In contrast, MBP p35-47 primed lymphocytesisolated from SJL/J
and BIOS (H-23[I-A3]), strains that do not express I-E, did not proliferate in vitro
Strain Peptide Incidence Severity"
Day of
onset
PL/J p30-52 3/5 3.0 17
PL/J p35-47 12/15 3.5 12
PL/J p30-45 0/15 - -
PL/J Rat MBP 8/15 2.5 19
SJL/J p35-47 0/20 - -
SJL/J p30-45 0/15 - -
SJL/J Rat MBP 6/10 2.5 20
(PLSJ)Fl p30-52 3/5 4.1 14
(PLSJ)F, p35-47 11/15 4.3 12
(PLSJ)Fl p30-45 0/15 - -
(PLSJ)Fl Rat MBP 14/20 3.8 171184
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TABLE II
Peptide Specificity, Class II Restriction, and TCR VJ38 Expression of
MBP-speck T Cell Clones
* All T cell clones were isolated from separate T cell lines except for
PJp5-5.2 (Vp8 + ) and PJ5-5 .9 (Vp8 - ), which were isolated from the
same line. Clones PJR-25 and PJB-20 have been described (2).
1 T cell clones were stained with Vp8-specific mAb as described (6).
with p35-47. Thus, within these strains, T cell recognition ofencephalitogenic de-
terminant p35-47 is restricted by I-E molecules.
It has been suggested that TCR Vp chain expression may correlate with MHC
restriction(8). In one investigation, which examined Vp expression ofT cell clones
isolated from DBA/2(H-2d) mice that were specific for sperm whale myoglobin, it
was demonstrated that most clones using a member of the Vp8 subfamily were re-
stricted by I-E, whereas Vp8- clones were I-A restricted (8). Although only 20%
PL/J peripheral T cells express Vp8, we have observed that -80% of PL/J MBP
pl-11-specific clones, restricted by I-A, use TCR Vp8 (6). None of 11 I-E-restricted
p35-47-specific clones use TCR Vp8. Six ofseven I-A-restricted clones that recog-
nize p5-16, a nonencephalitogenic MBP epitope, are V08' . Representative clones
are shown in Table II. In contrast with Morel (8), ifVp usage correlates with MHC
restriction, in PL/J mice, Vp8 expression may correlate with I-A restriction.
Encephalitogenic determinants within MBP 1-37 and 89-169 were recentlyidentified
(2, 3) (Table III). Since T cell clones have been isolated that recognize epitopes of
mouse(self) MBPdistinct from MBP 1-37 and 89-169, we have suspectedthat other
"cryptic"encephalitogenic MBP determinants may exist. By examiningthe specificity
ofanencephalitogenic Tcell clonethat recognizes a distinct epitope ofmouse (self)
MBP, we have identified encephalitogenic epitope p35-47 . It is clear that there are
multiple (atleastthree) discrete encephalitogenic T cell epitopes ofthe autoantigen
MBP
In mice, two isotypic class II molecules can be expressed, I-A and I-E. I-A is the
homologue of HLA-DQand I-E is the homologue of HLA-DR (9). Susceptibility
Clone* Origin Immunization
MBP
specificity
Class II
restriction
TCR
Vp8:
P1 .5 PL/J p30-52 p35-47 EQuEpu
P2.1 PL/J p30-52 p35-47 EQu
Ep
u
P6.6 PL/J p30-52 p35-47 Ec,"Ep u
F3 .3 (PLSJ)Fl p30-52 p35-47 EQuEpu
Fj-28 (PLSJ)Fl Rat MBP p35-47 EauEps
PJR-25 PL/J Rat MBP PI-9 AauApu +
PJB-20 PL/J Bovine MBP pl-9 AauApu +
PJpR8.1 PL/J pRl-11 PI-9 AauApu +
PJpR-9.6 PL/J pRl-11 pl-9 AauApu -
PJpBR-6.3 PL/J pRl-I1 pl-9 AauApu +
PJp5-1 .1 PRL/J pR5-16 pR5-16 AauApu +
PJp5-2.1 PL/J pR5-16 pR5-16 AauApu +
PJp5-3 .7 PL/J pR5-16 pR5-16 AauApu +
PJp5-4.6 PL/J pR5-16 pR5-16 AauAp° +
PJp5-5.2 PL/J pR5-16 pR5-16 AauApu +
PJp5-5.9 PL/J pR5-16 pR5-16 AauApu -
PJp5-6 .2 PL/J pR5-16 pR5-16 AauApu +ZAMVIL ET AL.
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TABLE III
Multiple Discrete Encephalitogenic T Cell Epitopes ofMBP
to several murine autoimmune diseases including EAE (1-3) and diabetes (10) is
associated with specific allelic I-A class II molecules. Although certain investiga-
tions indicate that I-E expression is involved in susceptibility (11) or resistance (10)
to certaindiseases, antigen-specific I-E-restrictedT cellsthatparticipate in the patho-
genesis ofmurine diseasehave notbeen previously identified. Inthis report, we have
identified encephalitogenic epitope, MBP p35-47, whose recognition is restricted
only by I-E class II molecules. It is now clearthat T cells restricted by I-E, the mu-
rine homolog of HLA-DR, participate in autoimmune disease.
Susceptibility to certain human autoimmune diseases is linked to more than one
class IImolecule (12). Forexample, susceptibility to insulin-dependentdiabetes mellitis,
a disease thought to involve T cells, is associated with both HLA-DR3 and HLA-
DR4 (12). Although it is unclear why there are multiple class II associations with
certain diseases, one possibility is that there are separate T cell antigens or separate
determinants ofa single autoantigen, each recognized in association with distinct
class II molecules. Our studies demonstrate that there are multiple discrete T cell
epitopes of the autoantigen MBP (Table III), each recognized in association with
separate allelic class II molecules. Discrete T cell epitopes, as we have identified,
could, in part, account forthe association ofmore than one class II (HLA-D) mole-
cule with susceptibility to certain autoimmune diseases.
Summary
Immunization withtheautoantigenmyelin basicprotein(MBP) causes experimental
allergic encephalomyelitis (EAE). Initial investigations indicated that encephalito-
genic murine determinants ofMBP were located only within MBP 1-37 and MBP
89-169. EncephalitogenicT cellepitopes within thesefragments havebeen identified.
Each epitope is recognized by Tcells in association with separate allelic I-A mole-
cules. A hybrid I-E-restricted T cell clone that recognizes intact mouse (self) MBP
has been examined. The epitope recognized by this clone includes MBP residues
35-47. When tested in vivo, p35-47 causes EAE. T cell recognition ofp35-47 occurs
only in association with I-E molecules. These resultsprovide the first clear example
that antigen-specific Tcells restricted byI-E class II molecules participate in murine
autoimmune disease. Furthermore, it is clear that there are multiple (at least three)
discrete encephalitogenic Tcellepitopes ofthis autoantigen, each recognized in as-
sociation with separate allelic class II molecules. These results may be relevant to
human autoimmune diseaseswhose susceptibility is associated with more than one
HLA-D molecule.
Peptide
Encephalitogenic
potential
Class II
restriction
MBP 1-11 + AauApu
MBP 5-16 - AauADu
AasASu
MBP 35-47 + EauE9u
EauE9s
MBP 89-101 + AasAS s1186
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